4//SEC Filing
Howe Jill Ann 4
Accession 0000950170-24-131098
CIK 0000876343other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 4:58 PM ET
Size
5.1 KB
Accession
0000950170-24-131098
Insider Transaction Report
Form 4
Howe Jill Ann
Chief Financial Officer
Transactions
- Purchase
Common Shares
2024-11-26$0.59/sh+15,000$8,850→ 25,500 total
Footnotes (1)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5925 to $0.5929, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1.
Documents
Issuer
Lineage Cell Therapeutics, Inc.
CIK 0000876343
Entity typeother
Related Parties
1- filerCIK 0001892397
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 4:58 PM ET
- Size
- 5.1 KB